Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1983 4
1984 5
1985 1
1986 2
1987 3
1988 2
1989 4
1990 3
1991 2
1992 2
1993 1
1994 8
1995 6
1996 6
1997 4
1998 9
1999 12
2000 9
2001 9
2002 7
2003 7
2004 12
2005 10
2006 18
2007 11
2008 21
2009 16
2010 15
2011 17
2012 19
2013 21
2014 16
2015 19
2016 8
2017 12
2018 9
2019 7
2020 5
2021 4
2022 4
2023 5
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. Andries K, et al. Among authors: jarlier v. Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9. Science. 2005. PMID: 15591164 Clinical Trial.
Multidrug and extensively drug-resistant tuberculosis.
Maitre T, Aubry A, Jarlier V, Robert J, Veziris N; CNR-MyRMA. Maitre T, et al. Among authors: jarlier v. Med Mal Infect. 2017 Feb;47(1):3-10. doi: 10.1016/j.medmal.2016.07.006. Med Mal Infect. 2017. PMID: 27637852 Review.
Healthcare-associated infections: think globally, act locally.
Marcel JP, Alfa M, Baquero F, Etienne J, Goossens H, Harbarth S, Hryniewicz W, Jarvis W, Kaku M, Leclercq R, Levy S, Mazel D, Nercelles P, Perl T, Pittet D, Vandenbroucke-Grauls C, Woodford N, Jarlier V. Marcel JP, et al. Among authors: jarlier v. Clin Microbiol Infect. 2008 Oct;14(10):895-907. doi: 10.1111/j.1469-0691.2008.02074.x. Clin Microbiol Infect. 2008. PMID: 18828851 Free article. Review.
[Resistance to antituberculous drugs].
Veziris N, Cambau E, Sougakoff W, Robert J, Jarlier V. Veziris N, et al. Among authors: jarlier v. Arch Pediatr. 2005 Aug;12 Suppl 2:S102-9. doi: 10.1016/s0929-693x(05)80024-7. Arch Pediatr. 2005. PMID: 16129320 Review. French.
Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France.
Amarsy R, Granger B, Fournier S, Monteil C, Trystram D, Siorat V, Jarlier V, Robert J; Members of the Collégiale de Bactériologue – Virologie – Hygiène. Amarsy R, et al. Among authors: jarlier v. J Hosp Infect. 2024 Jan;143:97-104. doi: 10.1016/j.jhin.2023.09.022. Epub 2023 Oct 28. J Hosp Infect. 2024. PMID: 37898407 Free article.
Broad-range PCR: past, present, or future of bacteriology?
Renvoisé A, Brossier F, Sougakoff W, Jarlier V, Aubry A. Renvoisé A, et al. Among authors: jarlier v. Med Mal Infect. 2013 Aug;43(8):322-30. doi: 10.1016/j.medmal.2013.06.003. Epub 2013 Jul 19. Med Mal Infect. 2013. PMID: 23876208 Review.
[Stop bacterial resistance: save antibiotics].
Carlet J; le groupe Alliance francophone contre le développement des bactéries multi-résistantes aux antibiotiques (AC-2-BMR). Carlet J, et al. Med Mal Infect. 2011 Jul;41(7):351-2. doi: 10.1016/j.medmal.2011.06.003. Epub 2011 Jul 20. Med Mal Infect. 2011. PMID: 21764235 French. No abstract available.
Surveillance of antimicrobial resistance--what, how and whither?
Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, Isham V, Jarlier V, Jones R, Phillips I, Sahm D, Senn S, Struelens M, Taylor D, White A. Bax R, et al. Among authors: jarlier v. Clin Microbiol Infect. 2001 Jun;7(6):316-25. doi: 10.1046/j.1198-743x.2001.00239.x. Clin Microbiol Infect. 2001. PMID: 11442565 Free article. Review.
[European Antibiotic Awareness Day: What is new in France?].
Pulcini C, Alfandari S, Ballereau F, Bonnet E, Bruneel F, Castan B, Chidiac C, Cohen R, Descamps D, Doco-Lecompte T, Gauzit R, Guéry B, Jarlier V, Lesprit P, Marcelin AG, Molina JM, Rabaud C, Riché A, Salmon-Céron D, Senneville E, Stahl JP, Tattevin P, Varon E, Roblot F; conseil d’administration de la SPILF. Pulcini C, et al. Among authors: jarlier v. Med Mal Infect. 2015 Sep;45(9):345-7. doi: 10.1016/j.medmal.2015.08.001. Epub 2015 Sep 26. Med Mal Infect. 2015. PMID: 26411783 French. No abstract available.
322 results